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mRNA degradationNanoRNase (Nrn) speciﬁcally degrades nucleoside 30,50-bisphosphate and the very short RNA, nanoR-
NA, during the ﬁnal step of mRNA degradation. The crystal structure of Nrn in complex with a reac-
tion product GMP was determined. The overall structure consists of two domains that are
interconnected by a ﬂexible loop and form a cleft. Two Mn2+ ions are coordinated by conserved res-
idues in the DHH motif of the N-terminal domain. GMP binds near the DHHA1 motif region in the C-
terminal domain. Our structure enables us to predict the substrate-bound form of Nrn as well as
other DHH/DHHA1 phosphoesterase family proteins.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
RNA metabolism is important for the regulation of gene expres-
sion. The mRNA levels are controlled by both the rate of their syn-
thesis and degradation. RNA degradation is mediated by many
different ribonucleases (RNases) [1]. In Escherichia coli, the degra-
dation of transcripts is initiated by the endonucleolytic cleavage
by RNase E [2]. The resulting fragments are then degraded by 30–
50 exoribonucleases, RNase II, RNase R and polynucleotide phos-
phorylase. However, these RNases cannot completely degrade
RNA to monoribonucleotides [3–5], but instead generate ‘‘nanoR-
NAs’’ that comprise very short RNA species (2–5-mers) [6].Complete degradation of nanoRNAs is mediated by oligoribonuc-
lease (Orn), one of the two essential RNases in E. coli [7,8]. Recently,
it was shown that nanoRNA can act as a primer for transcription
initiation and thereby alter global gene expression [9,10]. Although
the degradation of nanoRNA is important, many bacteria lack a
homologue of Orn. NanoRNase (Nrn), which was ﬁrst identiﬁed
in Bacillus subtilis, is the functional homologue of Orn [11]. Nrn
homologues are found in Firmicutes, Bacteroidetes, Chlorobi, the
r and e subdivisions of Proteobacteria, Actinobacteria, Cre-
narchaeota and Euryarchaeota, whereas Orn homologues are ab-
sent in these species [11].
Nrn is a member of DHH phosphoesterase superfamily, one of
the phosphodiesterase superfamilies [12]. The DHH superfamily
is divided into two subfamilies, DHHA1 and DHHA2, which share
conserved N-terminal motifs but possess different C-terminal mo-
tifs. The DHH/DHHA1 subfamily includes Nrn as well as RecJ, a 50–
30 single-strand DNA (ssDNA)-speciﬁc exonuclease, which acts in
DNA repair and homologous recombination. We previously re-
ported that TTHA0118 (ttNrn), an Nrn homologue from Thermus
thermophilus HB8, degrades nanoRNAs and very short ssDNA in a
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[13]. ttNrn also hydrolyzes adenosine 30,50-bisphosphate (pAp) to
give 50-AMP [13]. The biochemical characteristics of some Nrn pro-
teins have also been investigated [14–16]. However, the molecular
mechanism of the activity of Nrn, including its preference for short
nucleotides, remains unclear. In addition, another DHH/DHHA1
family protein YybT hydrolyzes bacterial signaling molecules,
bis-(30,50)-cyclic diadenylic acid (c-di-AMP) and bis-(30,50)-cyclic
diguanylic acid (c-di-GMP) yielding 50-pApA and 50-pGpG, respec-
tively, but does not act on pAp, nanoRNA or ssDNA [17,18]. The
molecular basis for this difference in substrate speciﬁcity between
DHH/DHHA1 family proteins is not understood.
To date, two crystal structures of Nrn homologues from Bacte-
roides fragilis (PDB ID: 3DMA) and Staphylococcus haemolyticus
(PDB ID: 3DEV) have been determined, although these ﬁndings
are not reported in the literature. We previously described the
crystal structure of full-length RecJ from T. thermophilus HB8
(ttRecJ) [19]. These studies revealed the active site includes two
metal cations, but the requirements for substrate recognition re-
main unclear. The C-Ala domain of alanyl-tRNA synthetase is also
annotated as a DHHA1 domain in the Pfam database. Moreover,
this C-Ala domain alone has been shown to bind tRNA with high
afﬁnity [20]. Although the DHHA1 domain is thought to have
RNA-binding function, the structural basis for this interaction is
unknown.
Here, we report the crystal structure of Nrn from B. fragilis
(bfNrn) as a Mn2+–GMP complex. This is the ﬁrst study to deter-
mine the ligand-bound form of a DHH/DHHA1 phosphoesterase
family protein and demonstrate that the DHHA1 motif is required
for ligand binding.
2. Materials and methods
2.1. Materials and assays
Polypeptone and yeast extract for cultivating E. coli were ob-
tained from Difco (Detroit, MI). The oligoribonucleotides were syn-
thesized by BEX Co. Ltd. (Nagoya, Japan). All other reagents used
were of the highest commercially available grade. Puriﬁcation
and enzymatic assay of bfNrn were performed as described in Sup-
plementary methods.
2.2. Crystallization, data collection, and structure determination
Crystallization of bfNrn–Mn2+–GMP complex was performed by
the hanging drop vapor diffusion method. Drops (1 ll) of 3.5 mg/
ml protein solution were mixed with 1 ll of 0.1 M sodium acetate
trihydrate (pH 5.3), 1.6 M NaCl, 20 mM MnCl2 and 10 mM guano-
sine 30,50-bisphosphate (pGp) and equilibrated against 0.1 ml of
the reservoir solution at 20 C. For cryoprotection, the crystal was
soaked in a drop of the crystallization solution containing 20 mM
MnCl2 and 25% glycerol. The crystals were then ﬂash-frozen in a
stream of liquid nitrogen (180 C). Single-wavelength diffraction
data at 1.000 and 1.892 Å were collected at beamline BL26B2 at
SPring-8 (Hyogo, Japan). The diffraction images were processed
using the program HKL2000 [21]. An examination of the data using
phenix.xtriage [22] indicated that the crystal was not twinned. The
structure was determined by molecular replacement with MOLREP
[23] using the free form structure of bfNrn (PDB ID: 3DMA) as the
model. The reﬁnement was carried out using the following pro-
grams; CCP4 suite [24], Refmac5 [25], CNS [26] and Coot [27]. In
the reﬁnement process, we ﬁrst built the structure with the 2Fo-
Fc and Fo-Fc maps calculated by Refmac5. We then carried out
iterative rounds of energy minimization, individual B-factor reﬁne-
ment using CNS, and manual model correction using Coot withomit map calculated by CNS to reduce the effects of model bias.
The model structure of bfNrn-Mn2+-4 mer RNA (50-UUUU-30) was
built using Pymol [28].
3. Results and discussion
3.1. Activity of bfNrn
We ﬁrst measured exonuclease activity of bfNrn against ssDNA
of different length. Prior to this study, there was only one report
describing the biochemical activity of bfNrn, which stated the en-
zyme hydrolyzes 20,30-cAMP to 30-AMP [29]. Here, we found bfNrn
degraded 11-mer ssDNA to mononucleotide in a Mn2+-dependent
manner (Supplementary Fig. S1A). The 50 end of the substrate
was labeled with 32P, and mononucleotide as the product was
found predominantly. This result suggested that bfNrn has exonu-
clease activity with 50 to 30 polarity. It should be noted, however,
that a faint band seemed to be found just below the band of the
substrate 11-mer ssDNA. Mass spectrometric analysis of the reac-
tion product also suggested that the substrate was degraded both
with 50–30 and 30–50 exonuclease activity (Supplementary Fig. S2)
although it was difﬁcult to determine quantitatively which activity
was primary. It was previously suggested that an Nrn homologue
(Mpn140) of Mycoplasma pneumoniae changes its polarity of exo-
nuclease activity with the nature of the substrate [16]. In addition,
bfNrn hydrolyzed 3-mer more efﬁciently than 6- and 11-mer (Sup-
plementary Fig. S1B). Thus, bfNrn preferentially hydrolyzes short
ssDNA, which is similar to other Nrn homologues.
Next, we examined phosphatase activity. bfNrn degraded pAp
(30,50-pAp) to 50-AMP, but not adenosine 20,50-bisphosphate
(20,50-pAp) in the presence of Mn2+ ions (Supplementary
Fig. S3A,B), indicating 30 phosphatase activity. Moreover, bfNrn
showed phosphatase activity against 30-AMP and yielded adeno-
sine (Supplementary Fig. S3C), but the amount of the product
was less for 30-AMP than pAp after the same reaction time (Supple-
mentary Fig. S3F). These results indicate that the 50-phosphate
group contributes to the phosphatase activity of bfNrn, but is not
essential. bfNrn also degraded pGp to 50-GMP (Supplementary
Fig. S3D), suggesting no base speciﬁcity of the phosphatase activity
of bfNrn. Interestingly, bfNrn degraded c-di-GMP to generate 50-
GMP (Supplementary Fig. S3E). We conclude that 30-phosphatase
activity produces two 50-GMP molecules from one c-di-GMP mole-
cule. This degradation pattern is different from that of YybT, which
generates 50-pGpG from c-di-GMP [18]. Except for pAp, the activity
of Nrn against these substrates has not been reported. c-di-GMP is
a signaling molecule involved in bacterial virulence, infectiousness,
pathogenesis and bioﬁlm formation [30]. pGp is the product of
hydrolysis of bacterial alarmone ppGpp by Ndx8 in T. thermophilus
HB8 [30,31]. Thus, it is possible that Nrn acts not only in the mRNA
degradation pathway but also in signaling pathway.
3.2. Overall structure of bfNrn
We determined the crystal structure of bfNrn in complex with
Mn2+ and GMP at 2.95 Å resolution (Fig. 1). The crystal was ob-
tained by co-crystallization with pGp and MnCl2 i.e., a reaction
product GMP was generated during crystallization. Data collection
and reﬁnement statistics are shown in Supplementary Table S1.
The overall structures of bfNrn in a ligand-free form (PDB ID:
3DMA) and as a Mn2+–GMP complex are similar to each other
(the R.M.S.D. of 340 Ca atoms is 0.461). By size exclusion chroma-
tography, the apparent molecular mass of bfNrn was estimated to
be approximately 80000, suggesting that bfNrn exists in a dimeric
form in solution (data not shown). Although the asymmetric unit
contains only one protein chain, the results of the size exclusion
Fig. 1. Crystal structure of the bfNrn–Mn2+–GMP complex. (A) Stereo-view of the cartoon representation. The chain is color ramped from blue (N terminus) to red (C
terminus). Mn2+ ions are shown as spheres. GMP is represented by a stick model. (B) A homodimer in the crystal by crystallographic two fold axis. (C) Distribution of the B-
factor of main chain atoms. The B-factor is colored from high (red) to low (blue). (D) Electrostatic potential surface (positive potential, blue; negative potential, red). The GMP-
binding site is expanded (inset).
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ties suggest that the two monomers related by the crystallographic
two fold might form the biologically active entity (Fig. 1B).
The structure of the subunit can be divided into two structural
domains that are interconnected by a ﬂexible loop to form a cleft.
The N-terminal domain (residues 2–212) comprises parallel b-
sheet (b1–b6 surrounded by twelve a-helices. The C-terminal do-
main (residue 213–343) comprises anti-parallel b-sheet (b7–b12)
surrounded by six a-helices. The ﬁrst methionine, residues (283
and 284) in the loop regions and C-terminal His6-tag and a linker
(344–351) were found to be disordered. The average B-factor of
the C-terminal domain was higher than that of the N-terminal do-
main (Fig. 1C). The B-factor also tends to increase with distance
from the N-terminal domain, implying rigid body vibration of an
otherwise well-ordered C-terminal domain. The N-terminal do-
main contains DHH motifs I–IV forming the active site and coordi-
nating two Mn2+ ions, whereas the C-terminal domain contains the
DHHA1motif. GMP is located in the cleft between the two domains
and bound to the positive region formed by conserved basic resi-
dues near the DHHA1 motif (Supplementary Fig. S4) in the C-ter-
minal domain (Fig. 1D). In the following discussion, the N- and
C-terminal domains are referred to as the DHH and DHHA1 do-
main, respectively.
In the active site there are two Mn2+ ions (Mn1 and Mn2) in the
concave patch composed of residues from motifs I–IV. An anoma-
lous difference Fourier map at 1.892 Å (the Mn absorption edge)
showed two obvious peaks in one subunit above 5 r (Fig. 2A). Both
Mn1 andMn2 are coordinated by one nitrogen atom and three oxy-
gen atoms. Mn1 is coordinated by Asp35 (2.2 Å, motif I), Asp99
(2.3 Å, motif II), His125 (2.6 Å, motif III) and Asp177 (2.3 Å, motif
IV). Mn2 is coordinated by the side chains of Asp33 (2.2 Å and
2.6 Å, motif I), Asp99 (2.3 Å, motif II) and His29 (2.7 Å). Thecoordination of metal ions in bfNrn is similar to that of ttRecJ
(Fig. 2C), except the coordinating residue His29 in bfNrn is replaced
by Asp80 in ttRecJ. Also in the crystal structure of S. haemolyticus
Nrn (shNrn), this position is occupied by His23 (although the struc-
ture only has onemetal ion) (see Fig. 2B). The His residue at this po-
sition is highly conserved among Nrn homologues, whereas the Asp
residue at the corresponding position is conserved among RecJ res-
idues (Supplementary Fig. S4). Therefore, we conclude that this po-
sition in motif I of Nrn homologues is occupied by His, but not Asp.
Nevertheless, overall coordination geometry is common to both
Nrn and RecJ. Our ﬁndings suggest that the hydrolysis reaction cat-
alyzed by Nrn proceeds via a two-metal ion mechanism, as is the
case for RecJ [19]. After we positioned two Mn2+ ions, there still re-
mained the third peak in the 2Fo-Fc map. Because there was no
anomalous signal for this peak, we put awatermolecule in this den-
sity. It should be mentioned that the position of the water molecule
in the active site of bfNrn is different from that in ttRecJ (Fig. 2A and
C). Interestingly, the corresponding position to His29 in bfNrn is
occupied by His and Asn in type II inorganic pyrophosphatase and
exopolyphosphatase, respectively, which belong to the DHH family
[32]. The substrate of the former, pyrophosphate, is smaller than
that of the latter, polyphosphate. The relationship between His/
Asn residue and short/long polyphosphate in these enzymes seems
similar to that between His/Asp and short/long nucleic acid in Nrn/
RecJ. Hence, the residue at this position could be important in deter-
mining substrate preference.
3.3. Ligand-binding site
GMP (guanosine 50-phosphate) is located near the GGGH resi-
dues (Supplementary Fig. S5A), which comprise the conserved mo-
tif in the DHHA1 family (Supplementary Fig. S4). GMP interacts
Fig. 2. Metal ion-binding site. (A) Mn2+-binding site of bfNrn. Electron density (magenta) of the Mn2+ ions derived from an anomalous difference Fourier map (k = 1.892 Å) is
superimposed on the model. The positions of the Mn2+ ions are shown as a magenta sphere. Water molecules are shown as cyan spheres. The dashed lines show the
coordination with the metal ion (distances given in Å). (B) Mg2+-binding site of shNrn (PDB ID: 3DEV). The position of the Mg2+ ion is shown by a green sphere. (C) Mn2+-
binding site of ttRecJ ttRecJ (PDB ID: 2ZXP). The motif names are indicated in parentheses.
2672 Y. Uemura et al. / FEBS Letters 587 (2013) 2669–2674with Arg105 in the DHH domain and Lys287, Ser289 and Arg291 in
the DHHA1 domain (Fig. 3). To our knowledge, this is one of the
ﬁrst structural studies to show that the DHHA1 domain is directly
involved in ligand binding, which was suggested previously [20].
As mentioned about C-Ala domain of alanyl-tRNA synthetase
[20], the short b-strand (b11) formed by the DHHA1 motif (GGGH
residues) in bfNrn is bent downwards (Supplementary Fig. S5B).
Moreover, the conformation of b11 facilitates the formation of
the concave patch on the molecular surface.
The oxygen atom of the 50-phosphate group of GMP interacts
with Lys287 (3.3 Å), Ser289 (2.9 Å) and Arg291 (2.5 Å) (Fig. 3).
Arg291 is completely conserved among Nrn proteins. The side
chain of Arg291 is closer to GMP in the Mn2+–GMP complex com-
pared to the ligand-free form (Supplementary Fig. S5C), which is
the only movement observed upon GMP binding. The 20-hydroxyl
group of the ribose moiety makes a hydrogen bond (3.1 Å) with
the side chain of Arg105, which is highly conserved in Nrn. The
30-hydroxyl group, which is generated by hydrolysis of the 30-phos-
phate of pGp have no contact with the protein. In the guanine
moiety, the main-chain carbonyl group of Gly309 is at a distanceFig. 3. GMP-binding site. The positions of the Mn2+ ions are shown by a magenta
sphere. The dashed lines indicate the distances (Å).of 3.1 Å from N-3 atom. This is consistent with our ﬁnding that
the phosphatase activity of bfNrn displays no base speciﬁcity.
The 30-hydroxyl group of the ribose moiety and Mn2+ ions in the
DHH domain are too far apart to interact (>6 Å) (Fig. 3). Given that
GMP is a product of pGp hydrolysis, the substrate-bound form of
the enzyme could be different from the determined structure.
The 30 scissile phosphate is predicted to be close to the metal-bind-
ing site for catalysis. Thus, we hypothesize that the two domains
move close to each other to form the catalytically active conforma-
tion. Indeed, the average B-factor of the DHHA1 domain is higher
than that of the DHH domain (Fig. 1C). Inorganic pyrophosphatases
belonging to the DHH superfamily also fold into two domains and
the C-terminal domain move closer to the N-terminal domain by
rigid-body rotation around the hinge axis upon substrate binding
[33]. Thus, the DHHA1 domain could move close to the DHH do-
main. If such domain movement occurs, the 30-hydroxyl group
would be located closer to Mn1 than the 50-hydroxyl group. This
domain movement is in accordance with the observed 30 phospha-
tase activity against pGp as well as pAp and 30-AMP. Assuming ri-
gid body movement of the DHHA1 domain relative to the DHH
domain, molecular recognition of the product GMP in the deter-
mined structure would reﬂect that of the substrate. The following
discussion concerning structure–function relationship is based on
these assumptions.
Recognition of the 50-phosphate group by Lys287, Ser289 and
Arg291 is consistent with the result of the phosphatase assay,
which indicated some contribution of the 50-phosphate to the en-
zyme activity (Fig. 3). However, the 50-phosphorylation does not
affect the exonuclease activity of ttNrn against 11-mer ssDNA
[13]. This observation suggests a difference in the detailed mecha-
nism of substrate recognition between mononucleotide and oligo-
ribonucleotide. Lys287 and Arg291 of bfNrn correspond to Lys366
and Arg370 of ttRecJ, respectively (Supplementary Fig. S5D).
Although these residues are also conserved in RecJ (Supplementary
Fig. S4), the 50-phosphorylation status does not affect its exonucle-
ase activity [34]. This observation suggests other residues contrib-
ute to substrate recognition in RecJ [19].
The side chain of Arg105 makes a hydrogen bond (3.3 Å) with
the 20-hydroxyl group of the ribose moiety. This seems inconsistent
with the observation that Nrn degrades both ssDNA and RNA to a
similar degree [13]. The distance between Arg105 and the 30-hy-
droxyl group is 4.1 Å. If the DHHA1 domain moves closer to the
DHH domain, it is possible that Arg105 could make contact with
the 30-phosphate group of the substrate. Arg105 is highly con-
served among Nrn enzymes, but not among other DHH/DHHA1
family proteins such as YybT and RecJ (Supplementary Fig. S4).
Fig. 4. A model structure of the bfNrn-nanoRNA complex. 4-mer RNA is shown as pink sticks. The position of each Mn2+ ion is shown as a magenta sphere.
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[18], whereas RecJ degrades only ssDNA [19]. Therefore, Arg105
might play an important role in substrate recognition of Nrn.
The lack of interaction with the guanine moiety of GMP is con-
sistent with our result of the phosphatase assay (Supplementary
Fig. S3).
The b strand (b11), which is made up of residues from the
DHHA1 motif, appears to be responsible for ligand binding
(Fig. 3). Among these residues, the side chain of His311 is located
at a distance of 4.1 Å from the 30-hydroxyl group of GMP (Fig. 3).
If the phosphate group is attached to the 30 position, His311 would
make contact with the substrate. Therefore, it is possible that
His311 is involved in substrate recognition even in the absence
of a conformational change. However, mutation of the correspond-
ing His residue in E. coli RecJ decreased the exonuclease activity
[35], suggesting that His311 plays a critical role in the activity. This
raises the possibility that His311 contributes to the catalytic step.
The distance between His311 and Mn1 is 6.6 Å (Fig. 3). Moreover,
the conserved His in the DHHA1 motif of RecJ is located far away
(10 Å) from the metal ions in the DHH domain [19]. However,
based on the ‘‘domain closure’’ hypothesis outlined earlier, this
distance would decrease upon substrate binding (Supplementary
Supplementary Fig. S6). Indeed, the C-Ala domain of alanyl-tRNA
synthetase does not have this conserved His residue but can still
bind tRNA with high afﬁnity [20].
3.4. Model for the bfNrn-nanoRNA complex
Based on this study and previous studies, we construct a model
structure of the bfNrn-nanoRNA (4-mer RNA) complex (Fig. 4).
First we used a model structure of ttRecJ-ssDNA complex as a ref-
erence [19]. In addition, we utilized structural information of
shNrn for positioning the substrate. In the structure of shNrn
(PDB ID: 3DEV), there are three sulfate ions per two subunits (Sup-
plementary Fig. S7). Two of the sulfate ions are located at almost
the same position as the 50-phosphate group of GMP in the
bfNrn–Mn2+–GMP complex, while the other sulfate ion is located
on the dimer axis. We assume that the positions of the sulfate ions
correspond to those of the phosphate groups of the substrate RNA.
Based on this assumption, the 50-end of the substrate RNA is posi-
tioned at that of GMP in the bfNrn–Mn2+–GMP complex i.e., GMP
corresponds to the nucleotide at the 50-end of the substrate. More-
over, the position of an internal phosphate group of the substrate
was aligned to that of the sulfate ion on the dimer axis. In theconstructed model structure, four nucleotide units are ﬁtted to
the length of the cleft between the two domains (Fig. 4).
Based on these ﬁndings, we can speculate on the structure–
function relationship of Nrn, especially in terms of preference for
substrate length. Our previous study on the exonuclease activity
of ttNrn revealed that the Km values for the substrates were all
within a relatively narrow range, whereas kcat values increased
by 5 orders of magnitude as ssDNA length decreased from 21-
mer to 3-mer [13]. Analysis of the model structure shows the sub-
strate-binding site (i.e., cleft between DHH and DHHA1 domains)
has sufﬁcient length to accommodate a 4-mer oligonucleotide. This
is consistent with similar Km values for ssDNA of various lengths.
However, our reaction model necessitates domain closure before
the catalytic reaction can proceed. For substrates shorter than a
4-mer, domain closure can occur. However, the 30-tail portion of
a substrate longer than a 4-mer might protrude from the cleft near
the linker (hinge) region. This mode of binding would hamper do-
main closure and inhibit the catalytic reaction. Further study is
needed to verify our structural model and test our hypothesis con-
cerning the reaction mechanism.
4. PDB accession numbers
Coordinates and structure factors for the crystal structure of
bfNrn–Mn2+–GMP have been deposited in the PDB with PDB ID:
3W5W.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2013.
06.053.
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